Clinhope Consulting
Tailored Support For Clinical Success

ClinHope Consulting is a leading clinical research organization (CRO) that is transforming the clinical trial landscape through its distinct service model. Unlike most CROs offering comprehensive packages or niche solutions, ClinHope takes a flexible and personalized approach, allowing clients to choose individual solutions from an extensive suite of clinical trial services covering all stages, from development to post-market activities.

Fueled by a mission to help small pharmaceutical companies get their drugs to market faster, it simplifies the process of running clinical trials. It allows sponsors to carry out trials in regions like China and the U.S. and assists them in navigating regional regulatory hurdles and cultural barriers.

ClinHope was established in 2016 by three individuals with diverse backgrounds in clinical trial operations. Abby Chang, CEO, Landia Lin, director of ClinHope Consulting Corp. USA and Tammy Hsu, director of clinical operations, bring a wealth of experience gained from working in hospitals, global pharmaceutical companies and academic medical research facilities. Their combined knowledge allows them to understand client needs and use their connections with medical institutions to find solutions.

“Our team members draw from 10 to 15 years of clinical research experience so clients can rest assured their projects are overseen by seasoned professionals,” says Chang.

Flexibility and Customization

ClinHope’s track record of supporting over 30 clinical trials across numerous therapeutic areas, like oncology, cardiovascular, immunology, dermatology and ophthalmology, is a testament to its expertise and versatility. This resourcefulness is at the heart of the tailored services that accommodate sponsors’ diverse needs, allowing them to select specific offerings based on their requirements.

Whether it’s medical writing, early consultation or using expertise as a communication conduit with the FDA, clients can choose the services they need. This customizable approach is advantageous for foreign companies seeking to conduct specific parts of their studies in Taiwan, providing convenience and cost-effectiveness.

Specializing in study design and medical execution strategies, it offers bespoke, professional plans that prioritize efficiency and compliance with local and international laws. Every project is tailored to accommodate each location’s distinct clinical and trial environments for optimal outcomes.

A deep understanding of the laws and regulations governing clinical trials ensures adherence to ICH GCP guidelines and requirements set forth by regulatory authorities and ethics committees.

Clients often struggle to effectively communicate with study sites or establish rapport with principal investigators and institutional review boards (IRB). In response, ClinHope assumes a consultative role, leveraging its expertise to guide sponsors through the intricacies of study design and site interactions. Prior to protocol submission, it assists sponsors in identifying potential challenges and refining study protocols to align with clinical settings and IRB criteria. This enables sponsors to be well-prepared to navigate the complexities of the study process, enhancing the likelihood of successful outcomes.

Our team members draw from 10 to 15 years of clinical research experience so clients can rest assured their projects are overseen by seasoned professionals

Before beginning a study, ClinHope presents sponsors with clinical and marketing strategies to guide them. It entails considering the global regulatory landscape and restrictions to provide recommendations for potential clinical trial locations and strategies based on policy nuances and market dynamics.

This deep dive provides insight into the optimal market positioning for their product across different regions.

Facilitating Clinical Trials Worldwide

A significant advantage is ClinHope’s strategic location in Taiwan, facilitating strong business relationships across Japan, Southeast Asia and China. A U.S. presence in Houston, Texas, home to one of the largest medical centers, also offers clients expansive opportunities to conduct studies of varying scales.

The geographical advantage also facilitates conducting preliminary studies. Based on the results, sponsors can gain valuable insights into the potential market viability of their products without pre-emptively committing substantial resources to a region.

Proficiency in Mandarin is another benefit as it facilitates communication and navigates the nuanced business culture in China, a much-appreciable perk for U.S. sponsors. A cooperative CRO partnership opens avenues for research activities involving medical devices and new drugs.

It also aids Asian companies conducting studies in the U.S. that may encounter challenges due to disparities in data requirements between regions, as data collected in Asia may not always meet the criteria for U.S. registration.

“We help clients have effective discussions with the FDA and find scientific data that can back their claims and decrease the number of requirements they need for their product to be registered in the U.S.,” says Lin.

A notable achievement, particularly in its U.S. operations, involved leveraging the FDA’s pre-submission program to benefit a client undertaking a comprehensive study. Recognizing the potential of this new initiative, ClinHope advised the client to seek guidance from the FDA regarding their existing test data and the feasibility of conducting a full study in the U.S.

A meticulously prepared pre-submission package and study protocol was submitted to the FDA.

The FDA’s response proved invaluable. Constructive feedback allowed the client to reassess their testing requirements and address any deficiencies before proceeding with the study. The proactive methodology saved the client significant resources that would have otherwise been spent on an ineffective study.

A Company Culture of Teamwork

Teamwork is at the heart of ClinHope’s successful trajectory in the industry. The company’s culture is based on collaboration and cooperation, integrating input from various departments, including clinical sites, project management, clinical management, medical writing and regulatory affairs. This collective approach ensures that the output provided to sponsors is comprehensive and representative of all critical aspects of the project.

Cultivating a positive work environment is a priority, and the happiness and satisfaction of its employees is valued. It believes that fostering job satisfaction is essential for enhancing the overall quality of its services and, as a result, maintains an exceptionally low turnover rate of its staff. Its workplace, where employees feel valued and content, cultivates a dedicated and motivated team that contributes to delivering high-quality service to its clients.

Standing as a pillar of support in the biopharma space, ClinHope’s strategic global presence, paired with a flexible service, allows it to empower pharmaceutical companies to navigate the complexities of clinical trials and attain post-market success.